A Study of Pegasys (Peginterferon Alfa-2a) Administered Alone or in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C Who Have Participated in Previous Pegasys Trials
Clinical trial NCT01853254 · COMPLETED
Trial details
- NCT number
- NCT01853254
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-09-01
- Primary completion
- 2011-09-01
- Enrollment
- 272
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.